2^ND LARIX INTERNATIONAL SUMMIT ON INTERNAL MEDICINE

LISIM 2026

We are pleased to announce the 2nd Larix International Summit on Internal Medicine (LISIM 2026), to be held from April 12–15, 2026, in Kunming, China. This prestigious summit will bring together leading medicine specialists, pulmonologists, cardiologists, endocrinologists, gastroenterologists, hepatologists, nephrologists, general practitioners, and medical residents from around the world.

The program will feature high-quality scientific sessions highlighting the latest advancements and emerging, time-critical topics in internal medicine. Key focus areas include infectious diseases, rheumatic disorders, pulmonary and cardiovascular diseases, endocrine and neurological conditions, digestive and kidney diseases, tropical medicine, critical care, palliative care, clinical research, and many other relevant disciplines.

ABOUT LARIX INTERNATIONAL

Larix International is a publishing and conference planning organization committed to the global dissemination of scientific knowledge. Doctors, engineers, and scientists who were passionate about scientific advancements and wanted to produce high-caliber scientists and technologists co-founded Larix International. Through the development of an executive network of strategic alliances, we are able to provide real-time innovations by assisting our international researchers in fulfilling their vision, mission, and long-term strategic objectives.

THEMES OF THE SUMMIT

Session # 01: Infectious Diseases

·       Climate change and infectious disease: a review of evidence and research trends.

·       Antibiotics, antibiotic-resistant bacteria and resistance genes: risks, current concern and future thinking.

·       How to differentiate a bacterial infection from a colonization?

·       Artificial intelligence for modelling infectious disease epidemics.                

Session # 02: Rheumatic Diseases

·       Outlook of the latest guidelines for the treatment of rheumatoid arthritis.

·       Advances in the pathogenesis and treatment of systemic lupus erythematosus.

·       Effectiveness of physiotherapy in patients with ankylosing spondylitis.

·       Inflammation in osteoarthritis: the latest progress and ongoing challenges.          

Session # 03: Pulmonary Diseases

·       Advances in asthma: new understandings of asthma's natural history, risk factors, underlying mechanisms and clinical management.

·       The microbial etiology of community-acquired pneumonia: from classical bacteriology to host transcriptional signatures.

·       Pulmonary hypertension associated with lung disease: new insights into patho-mechanisms, diagnosis and management.

·       Artificial intelligence in COPD CT images: identification, staging, and quantitation.

Session # 04: Cardiovascular Diseases

·       Resistant hypertension: Diagnosis, evaluationand treatment practical approach.

·       Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutic approaches.

·       Postoperative atrial fibrillation: from mechanisms to treatment.

·       Heart failure management guidelines: new recommendations and implementation.                

Session # 05: Endocrine Diseases

·       From glucose lowering agents to disease-modifying drugs: anevidence-based approach for the treatment of type 2 diabetes.

·       Diagnosis and treatment of hyperglycemia in pregnancy: type 2 diabetes mellitus and gestational diabetes.

·       Approach to obesity treatment in primary care: insights form the clinical studies.

·       The management and metabolic characterization of hyperthyroidism and hypothyroidism.                

Session # 06: Neurological Diseases

·       The inter-relationship between delirium and dementia: the importance of delirium prevention.

·       Unraveling the genetic basis of epilepsy: Recent advances and implications for diagnosis and treatment.

·       Neuronal injuries in cerebral infarction and ischemic stroke: from mechanisms to treatment.

·       New perspectives in the diagnosis and management of Alzheimer’s disease.

Session # 07: Digestive Diseases

·       Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid.

·       Irritable bowel syndrome: controversies in diagnosis and management.

·       Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies.

·       New treatment paradigms in primary biliary cholangitis.                  

Session # 08: Kidney Diseases

·       Transition from acute kidney injury to chronic kidney disease: mechanisms, models and biomarkers.

·       Clinical practice guideline for the evaluation, management and treatment of autosomal dominant polycystic kidney disease.

·       Acute glomerulonephritis with concurrent suspected bacterial pneumonia: is it the tip of the iceberg?

·       Kidney stones, hypercalciuria, and recent insights into proximal tubule calcium reabsorption.                 

Session # 09: Tropical Diseases

·       Current status of malaria control and elimination: epidemiology, diagnosis, treatment, progress and challenges.

·       Dengue hemorrhagic fever: a growing global menace.

·       Updates on dengue vaccine and antiviral: where are we heading?

·       Chikungunya vaccine development, challenges, and pathway toward public health impact.

Session # 10: Critical Care

·       The effective management of shock: moving from physiology to guidelines to precision medicine and ultimately personalized medicine.

·       Bridging the gap: intensivists at the crossroads of clinical care and financial strategy.

·       Making sepsis the next success story in global health.

·       Augmented reality, simulation-based design, and other cutting-edge educational tools in critical care.

Session # 11: Palliative Care

·       Mapping of current practices of palliative care for patients with heart failure.

·       Evaluation of the palliative care day hospital for patients with advancedcancer.

·       Predictive symptoms of mortality in interstitial lung disease: findings from geriatrics and palliative care clinics.

·       Challenges in the decision-making process for sedation in palliative care: A qualitative interview study with healthcare professionals, patients and relatives.      

Session # 12: Clinical Research

·       AI tools for clinical research: the basics for internists.

·       How to write and publish an article: practical insights and innovative ideas.

·       Innovative digital techniques in data collection, data analysis and clinical research.

·       Advanced statistical methods in clinical research.

CALL FOR ABSTRACT

You are invited to submit your abstracts above topics. Based on the review of scientific committee, a limited number of abstracts will be selected for display and/or oral presentation.

Among the accepted abstracts, three principal authors will get the opportunity to be included in main scientific session as keynote speaker. Please read this Call for Abstracts information carefully before accessing the abstract submission form.

KEY DATES

Early Bird Registration: 15^th February, 2026

Abstract Submission Deadline: 05^th April 2026

Summit Date: 12 - 15^th April, 2026

WHO CAN ATTEND?

Medicine Specialists, Pulmonologists, Cardiologists, Endocrinologists, Gastroenterologists, Hepatologists, Nephrologists, General Practitioners and Residents.